ID

24339

Description

Study part: Adverse Events Baseline. An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169. Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.

Keywords

Versions (1)
  1. 7/30/17 7/30/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 30, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Adverse Events Baseline Ropinirole NCT00632736

English

Adverse Events Baseline

1 forms  
ADVERSE EVENTS
Description

ADVERSE EVENTS

Alias
UMLS CUI-1
C0877248
Any new adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events recorded in the appropriate Adverse Events/Serious Adverse Events section?
Description

Adverse Events

Data type

boolean

Alias
UMLS CUI [1]
C0877248
Back to the top of the page

Similar models

Adverse Events Baseline

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
ADVERSE EVENTS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Any new adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events recorded in the appropriate Adverse Events/Serious Adverse Events section?
boolean
C0877248 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial